From ADC to XDC: Opportunities and challenges for AI in revolutionizing drug conjugate development

^*此作品的通讯作者

科研成果: 期刊稿件 › 评论/辩论

4 引用（Scopus）

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

@article{9f5e94d2d3a74b8186e4a8d68b1e6268,

title = "From ADC to XDC: Opportunities and challenges for AI in revolutionizing drug conjugate development",

author = "Meijing Liu and Xiaogang Wang",

year = "2025",

month = feb,

day = "27",

doi = "10.59717/j.xinn-med.2024.100107",

language = "英语",

volume = "3",

journal = "Innovation Medicine",

issn = "2959-8745",

publisher = "Innovation Press",

number = "1",

}

TY - JOUR

T1 - From ADC to XDC

T2 - Opportunities and challenges for AI in revolutionizing drug conjugate development

AU - Liu, Meijing

AU - Wang, Xiaogang

PY - 2025/2/27

Y1 - 2025/2/27

UR - https://www.scopus.com/pages/publications/85219510524

U2 - 10.59717/j.xinn-med.2024.100107

DO - 10.59717/j.xinn-med.2024.100107

M3 - 评论/辩论

AN - SCOPUS:85219510524

SN - 2959-8745

VL - 3

JO - Innovation Medicine

JF - Innovation Medicine

IS - 1

M1 - 100107

ER -